0001628280-24-004111.txt : 20240209 0001628280-24-004111.hdr.sgml : 20240209 20240209170245 ACCESSION NUMBER: 0001628280-24-004111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240207 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nouri Alaleh CENTRAL INDEX KEY: 0001599418 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40797 FILM NUMBER: 24615969 MAIL ADDRESS: STREET 1: 1310 CHESAPEAKE TERRACE CITY: SUNNYVALE STATE: CA ZIP: 94089 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp CENTRAL INDEX KEY: 0001588978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 260199180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 6502329832 MAIL ADDRESS: STREET 1: 150 BAYTECH DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 4 1 wk-form4_1707516153.xml FORM 4 X0508 4 2024-02-07 0 0001588978 PROCEPT BioRobotics Corp PRCT 0001599418 Nouri Alaleh C/O PROCEPT BIOROBOTICS CORPORATION 150 BAYTECH DRIVE SAN JOSE CA 95134 0 1 0 0 EVP, CLO, CORP. SEC. 1 Common Stock 2024-02-07 4 M 0 5306 5.18 A 52657 D Common Stock 2024-02-07 4 S 0 5306 49.9535 D 47351 D Common Stock 2024-02-09 4 M 0 14694 5.18 A 62045 D Common Stock 2024-02-09 4 S 0 14694 49.9737 D 47351 D Stock Option (Right to Buy) 5.18 2024-02-07 4 M 0 5306 0 D 2030-08-08 Common Stock 5306 34819 D Stock Option (Right to Buy) 5.18 2024-02-09 4 M 0 14694 0 D 2030-08-08 Common Stock 14694 20125 D All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. The Stock option was granted on August 10, 2020 and vested 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date. /s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri 2024-02-09